|Last Price$12.75||Day Change (%)0.00%|
|Open Price$12.75||Day Change ($)0.00|
|Day Range12.75–12.75||52-Week Range12.12–12.80|
As of Mon 09/26/2016 | USD
Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.
Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.
Four candidates stood out from their growth counterparts.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
Most of Morningstar's top Medalists are shining in a pack of broad returns.